GAL3ST1 and renal carcinoma: Notably, platelets bind more efficiently to renal cancer cells with high GAL3ST1-sulfatide expression than to GAL3ST1-sulfatide-negative renal cancer cells, which protects ccRCC cells from NK cell-mediated cytotoxicity.